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The  HL-A  antigens,  with  the  possible  exception  of  the  ABO  blood  group 
antigens,  are proposed to be the most potent transplantation  antigens  in man 
(1,  2).  The  evidence for this  is indirect  and  rests mainly on the  differences in 
skin graft rejection  time and the behavior of renal allografts and bone marrow 
allografts  between  family  members  differing  at  one,  two,  or  neither  I-IL-A 
haplotypes  (3),  on  the  failure  of  leukocytes  from  H_L-A-identical  siblings  to 
stimulate  in  the  mixed  leukocyte  reaction  (MLR) 1 test  (4),  and  accelerated 
skin  graft  rejection  in  subjects  preimmunized  against  antigens  including  a 
designated  HL-A  specificity  (5).  It has  been  supposed  that  the  HL-A  deter- 
minant is divided into at least two subloci (6). At one point it was thought that 
the  first  antigens  to be detected  serologically would  prove  to be  the  antigens 
most  responsible  for  graft  rejection.  This  has  not  proven  to  be  correct. 
In the analogous situation in the mouse, where it was possible to test certain isolated 
specificifies,  incompatibility  for  what  was  thought  to  be  a  single  specificity 
correlated with delayed chronic skin graft rejection, and was easily overridden by en- 
hancing antiserum. Klein suggested that the potency of complex antigenic systems such 
as H2  results from cumulative effects of incompatibility for many specificities (7). In 
the  rat,  however,  Silvers  could not  distinguish  incompatibility  for Ag-B  against  a 
background of incompatibility for many non-Ag-B factors (8). In the mouse, Andrus 
also could not distinguish  the immunogenicity for alleles b, k, d, or q against a back- 
ground of non-H2 antigens  (9). A distinction  between Ag-B and non-Ag-B could be 
made in the rat after mild immunosuppression  (8),  and in the mouse the H2 alleles 
seemed to be unequal in their effect in skin graft rejection when non-H2 differences 
were eliminated (10). In the absence of data from immunosuppressed matched human 
subjects, evidence must be sought from a large series of test skin grafts between care- 
* Supported in part by Grant No. 2 R01 A. I. 998-02,  Am  13084, and by Veterans  Ad- 
ministration  Surgical Research Funds. 
1  Abbreviations used in this paper: MLR, mixed  leukocyte reaction;  PCA, perchloric  acid; 
SGST,  skin graft survival times. 
411 412  IMMUNOGENICITY OF  HUMAN HL-A  HAPLOTYPES 
fully serotyped nonimmunosuppressed human subjects and from results of the MLR. 
It must be kept in mind that it has not been proven that antigens detected serologically 
are those detected in the MLR. It may be that the locus that controls the MLR and the 
one that controls HL-A are not identical, and that the MLR activator in the respond- 
ing cell may be under the control of a  different genetic system altogether from that 
which controls the response mechanism in the cell (10).  The MLR  test has been re- 
ported to distinguish among related cell donors differing with respect to the number of 
incompatible HL-A alleles (11). It has also been stated that for related individuals there 
is  a  close  correlation between  the  MLR  and  skin graft  survival  time  (12).  In  the 
selection of related donors in our own renal transplantation program,  MLR  and skin 
grafting experiments are frequently employed  to  augment serological data. 
Our  findings  suggest  that  the  MLR  test  frequently  does  not  distinguish 
among  the  three  classes  of  related  donors  (none,  one,  or  two  HL-A  alleles 
different),  and  the  correlation  between  skin  graft  survival  time  and  MLR  is 
low. Results indicate that attempts to quantitate the MLR  should be cautiously 
interpreted. 
Materials and Melk~ds 
31 families, each including a potential renal transplant recipient, were tested with a panel 
of  antisera capable of detecting the World Health Organization recognized antigens HL-A 
1-12 as well as additional specificities not yet officially  recognized. A  two-stage semimicro- 
cytotoxicity dye-exclusion test was employed (13).  The inheritance of the four HL-A alleles 
in each family was established by haplotype analysis (14). Skin grafts were exchanged between 
selected family pairs by the method previously described (3).  No grafts were placed on the 
potential renal transplant recipient and all grafts were ABO-compatible. Whenever possible 
skin grafts were followed until rejected. 
One-way MLR were set up  between selected family members.  Heparinized  blood speci- 
mens were spun at 500 rpm for 15 min, and the plasma was removed and spun at 800 rpm for 
10 rain. The supernatant plasma was drawn  off  and  cleared  of platelets  by  centrifugation 
at  4000  rpm  for  15  min  and  saved  for  incorporation  into  the  media.  At  this  point 
the  white  cells  were  resuspended  in  their  autologous  tissue  culture  media.  The  stim- 
ulator  cells  were  then incubated with 0.05  cc mitomycin  C  per  cc  of  suspension  and 
incubated for  20  rain  at  37°C.  The  cells were  then washed three  times  and resuspended 
in  3.3  cc  of  tissue  culture  media  prepared  with autologous plasma.  Duplicates  of  3  X 
105  and  7  X  105 per  cc  of  mitomycin-treated  cells  were  utilized  as  stimulator  cells. 
At  this  point,  the  target  lymphoeytes  were  added  using  3  X  105  cells  per  cc  with 
the  total  volume  being set at  5.5  cc so  that duplicate cultures  of  2.5  cc  could  be  pre- 
pared.  The reactions were incubated at 37cC in a  CO~ incubator for a  7 day period. Mter 
the 7 day incubation, 20 #1 of tritiated thymidine was added to each tube and incubated for 
5 hr at 37°C.  After this, the reactions were kept at 4°C. An additional two drops of a  solution 
containing l/zCi/cc concentration of normal thymidine was added to each tube. After  cen- 
trifugation at 1500 rpm for 15 rain, the cells were washed three times with cold saline, and the 
cell pellet was precipitated using 7% perchloric acid (PCA). Each precipitate was collected on a 
glass filter acidified with 10 cc of 2 N hydrochloric acid, and washed with 10 cc of 95% ethanol. The 
filters were then thoroughly dried, placed in vialswith 10 cc of scintillation  cocktail, and counted 
in a  liquid scintillation counter. The degree of stimulation in each  test was expressed as  a 
ratio between the mixture and the appropriate control, called the stimulation index (15). SEIGLER,  WARD,  AMOS,  PHAUP,  AND  STICKEL  413 
RESULTS 
Duplicate MLR were compared to assess the reproducibility of the method. 
No  significant  difference between  the  duplicate  test was found  (t  [t-test]  = 
0.71,  df ]degrees of freedom]  ---  35,  P  =  0.5).  As a  further indication  of the 
reliability of the procedure employed, it should be noted that 45 of the 46 MLR 
between the HL-A-identical pairs did not result in a stimulation index greater 
than 2.5.  Stimulation indices of 1.5-2.5 must be considered borderline values in 
the  definition  of  "stimulation"  and  "nonstimulation".  A  stimulation  index 
greater than 2.5  clearly indicates stimulation. 
Comparison  of  MLR  with  HL-A  Alleles  and  Antigens.--Mixed  leukocyte 
TABLE  I 
Correlation of HLA with MLR 
Family pairs 
Unrelated 
HLA  One allele  Both HLA  stimulating 
alleles  cell  identicals  incompatible  incompatible 
Mean (X)  1.10  5.1  8.83  17.46 
Standard error (sE)  0.07  0.44  1.33  3.24 
Number (N)  46  133  33  37 
Coefficient of variation (C)  0.42  0.98  0.87  1.13 
Stimulation indices: means, standard errors, and coefficients of variation. 
reactions  between  212  family pairs  were  grouped  on  the  basis  of  the  HL-A 
genotypes of the paired individuals (Table I). The tests in which  the stimulating 
and  responding  cells were HL-A-identical showed  a  mean stimulation  index 
of 1.1 (sE =  0.68). This was significantly different (P =  0.05) from that of the 
MLR betweenpairs sharing only one HL-A allele (J~ [mean] =  5.12, SE  =  0.437) 
or sharing neither HL-A allele ()~  =  8.92,  SE  =  1.592).  The mean stimulation 
was greater when stimulator  and  responder shared neither  HL-A allele  than 
when they shared one; this difference was significant at P  <  0.05.  Stimulation 
indices in the three groups are plotted in Fig. 1. The distribution of the degree 
of  stimulation for the  group  sharing  one  allele  clearly overlaps  that  for the 
pairs differing with respect to two alleles. It should be further noted that there 
is  some overlap for  all three  groups,  occurring  at  the  stimulation  indices  of 
1.5-2.5. This is more clearly illustrated in Table II. None of the pairs differing 
with respect to two alleles failed to stimulate, but three pairs showed borderline 
stimulation with indices between 1.5  and 2.5.  Only one pair of HL-A identical 
siblings had a  stimulation index greater than 2.5  (the value being 2.8  in this 414  IMMUNOGENICITY  OF  HUMAN  ItL-A  ItAPLOTYPES 
case),  but  eight  reactions  between  HL-A-identical  siblings  had  borderline 
indices between  1.5  and 2.5. One-fourth of the reactions between related pairs 
sharing  only one allele  showed stimulation  indices less than 2.5; of these one- 
third clearly failed  to stimulate,  their  indices  being less than  1.5  (Table  III). 
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Fro. 1 
TABLE II 
Correlation of HLA  with MLR 
HLA alleles not shared 
Stimulation index 
<t.5  1.5-2.5  >2.~5  >5 
0  37  8  1  0 
1  11  23  49  50 
2  0  3  9  21 
X~ =  128.36, P  <  0.005. 
Distribution  of stimulation  indices among HLA classes. 
Thus,  the  degree  of  stimulation  in  each  group  was  variable,  and  for  those 
differing with respect to one allele,  the range of values was considerable. 
Although  none of the  healthy  family pairs  failed  to respond,  ll  of  the  31 
transplant patients failed to respond to any stimulating cell and were eliminated 
from all analyses.  10 of the  ll  patients  were on immunosuppression when the 
MLR  were  established.  Considering  the  possibility  that  these  patients  may 
have been generally weak responders or stimulators and hence may have biased 
the  data,  those  MLR  involving  patients  were  excluded  from  the  analysis SEIGLER,  WARD,  AMOS,  PHAUP,  AND  STICKEL 
TABLE  III 
Nonstimulation between .pairs Incompatible for One Allele 
415 
Family 
Genotype and HLA type of 
Stimulating cells  Responding cells 
Stimulation 
index 
Skin graft 
survival time 
0114  AD 2'LND 
1, 8 
0128  AC 1 or 11,8 
1 or i1, 5 
0183  CC' 2, Tel0 
1,  12 
2, 
0113  BC 11, 7 
2 or9 
0104  CD -- 
7 
0015  AC  1, 5 
(2, 3, or 9), 12 
1 
0206  BD i 
1 
0206  BC 
0206  AD 3,7 
1 
0206  AD 3, 7 
1 
0206  BD ~ 
CD 11, (LND)  1.2  15 
1, 8 
BC  --l°rll'5  1.2  8 
1 or ii, 5 
AC  3, 7  1.2  14 
2,Tel0 
2 
BD-  1.2  Not Done  2, 4c 
AD 2, 7 or 8  0.4  Not Done 
7 
BC  (2, 3, or 9)  1.0  11 
(2, 3, or 9),  12 
CD~  1.0  >15 
CD~  0.6  >15 
AB 3,__7  1.0  >15 
1 
AB 3,7  1.0  >15 
1 
1 
BC -  1.0  Not Done 
8 
TABLE  IV 
Distribution of Stimulation Indices among HL-A  Classes 
Number of HL-A 
alleles not shared 
Stimulation index 
< 1.5  1.5-2.5  > 2.5-5.0  > 5 
0  10  1  1  0 
1  5  11  35  37 
2  0  0  5  16 
x~  =  70.95 
.P  <  0.005 
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TABLE  V 
Mixed Leukocyte Reactions Measuring the Same IIL-A Incompatibility 
No. of  Stimu- 
Family  Stimulating  Responding  S-R**  HL-A-in-  Incompatible  SGST  lation 
cells (S)  cells (R)  "  compatible  HL-A groups~  +  ~ndex  alleles 
0099  03  02  AD : CD  1  --, 4c  22  2.5 
09  02  AD : CD  1  --, 4c  22  3.8 
02  08  CD:BD  1  ,  7  17  8.5 
02  10  CD:BD  1  ,7  28  5.8 
03  i0  AD:BD  1  ,  14  4.0 
09  10  AD:BD  1  ,  11  3.5 
09  08  AD:BD  1  ,  18  11.0 
10  09  BD:AD  1  --, LND  24  4.5 
08  09  BD:AD  1  --, LND  13  2.2 
0083  03  02  AC:CD  1  --, 8  >15  2.8 
04  04  AC:CD  1  --, 8  >15  3.8 
05  03  BD:AC  2  11,--§/,  7  ND  5.0 
05  04  BD:AC  2  11,--/,  7  ND  4.0 
0106  12  08  BC:BD  1  9, --  ND  16.0 
03  08  BC:BD  1  9, --  ND  5.5 
12  07  BC:AD  2  9,/-[i, LND  ND  26.0 
03  07  BC:AD  2  9,/., LND  ND  15.0 
0114  05  02  AD:CD  1  2, LND  15  1.8 
03  02  AD:CD  1  2, LND  15  1.2 
0139  03  04  AC:BD  2  2, 12/2 7  ND  3.5 
09  04  AC:BD  2  2, 12/2 7  ND  4.5 
0113  06  03  AC:AD  1  ,  ND  2.7 
07  03  AC :AD  1  ,  ND  6.5 
06  01  AC:AB  1  (11),:¶,  7  <15  5.0 
07  01  AC:AB  1  (11), 7  <15  13.2 
04  06  BD:AC  2  2, --/2, 4c  ND  40.0 
04  07  BD:AC  2  2, --2, 4c  ND  10.2 
** Genotypes of stimulating and responding cells. 
++ Antigens at first and second segregant series. 
§ Dash  (--)  indicates incompatible antigen not defined. 
II Period  (.)  indicates no incompatibility at the segregant series. 
¶  Parenthesis ( )  indicates uncertainty of antigen assignment. 
* This symbol occurring after 4c denotes an antibody which is broader than 4c. SEIGLER~  WARD~ AMOS,  PtIALTP~ AND  STICKEL  417 
TABLE V--Continued 
No. of  Stimu- 
Family  Stimulating Responding  S:R**  HL-A-in-  Incompat ible  SGST  lation 
cells (S)  cells (R)  compatible  HL-A  groups+  + 
alleles  index 
0159  22  21  BD:CD  1  ., --  ND  3.5 
23  21  BD:CD  1  ., --  ND  3.5 
0082  03  06  BC:AC  1  ,  ND  1.8 
05  06  BC:AC  1  ,  ND  3.0 
03  06  BC:AB  1  3, 7  ND  2.8 
05  01  BC:AB  1  3, 7  ND  4.2 
0015  05  09  BD:AD  1  (2, 3, 9), --  11  2.5 
06  09  BD:AD  1  (2, 3, 9), --  <11  6.5 
08  09  BD:AD  1  (2, 3, 9), --  <11  5.5 
0013  08  09  AC:BC  1  3, 5  <14  5.2 
06  09  AC:BC  1  3, 5  >14  6.5 
0206  04  02  AD:CD  1  3, 7  >15  13.0 
21  02  AD:CD  1  3, 7  >15  8.0 
04  01  AD:AB  1  ., --  >15  1.0 
21  01  AD:AB  1  ., --  >15  1.0 
0207  06  03  AD:AC  1  3, 7  ND  6.5 
06  05  AD:AC  1  3, 7  <15  5.0 
02  03  CD:AC  1  3, 7  ND  6.0 
02  05  CD:AC  1  3, 7  13  5.5 
01  03  AB:AC  1  --, (5, 7)  ND  6.5 
01  05  AB:AC  1  --, (5,  7)  15  6.0 
05  06  AC: AD  1  2, --  ND  6.5 
03  06  AC: AD  1  2, --  ND  7.5 
05  02  AC:CD  1  ,  16  3.2 
03  02  AC:CD  1  ,  ND  8.0 
05  01  AC:AB  1  2, --  15  7.0 
03  01  AC :AB  1  2, --  ND  5.0 
0208  02  03  CD: AC  1  --,  8  ND  3.2 
02  04  CD:AC  1  --, 8  14  5.0 418  IMMUNOGENICITY  OF  HUMAN  HL-A  IIAPLOTYPES 
TABLE V--Concluded 
Family 
No. of  Stimu-  Stimulating  Responding  S:R**  HL-A-in-  Incompatible  SGST  lation 
cells (S)  cells (R)  compatible  HL-A groups:~ 
alleles  index 
0208 
0209 
01  03  AB :AC  1  11, 4c*  ND  7.0 
01  04  AB:AC  1  11, 4c*  14  15.0 
03  02  AC:CD  1  9, --  ND  4.5 
04  02  AC:CD  1  9, --  ND  5.5 
04  01  AC:AB  1  3, 7  >15  11.5 
03  01  AC:AB  1  3, 7  ND  4.5 
02  03  CD:AD  1  (2, 9), --  ND  5.0 
02  03  CD:AD  1  (2, 9), --  13  2.5 
06  03  AC:AD  1  (2, 9), --  ND  5.5 
05  03  AC:AD  1  (2, 9), --  ND  6.0 
06  04  AC:AD  1  (2, 9), --  ND  6.0 
05  04  AC :AD  1  (2, 9), --  ND  10.0 
03  02  AD:CD  1  ., 7  ND  8.0 
04  02  AD:CD  1  ., 7  ND  7.0 
06  02  AC:CD  1  ., 7  ND  2.5 
05  02  AC:CD  1  ., 7  ND  4.0 
06  04  AC:AD  1  (2, 9), --  ND  6.0 
05  04  AC:AD  1  (2, 9), --  ND  10.0 
shown  in Table IV. As a  result of excluding  the cultures  involving patients,  a 
somewhat  clearer  distinction  between  HL-A-identical  siblings  and  those 
sharing  neither  allele was  observed.  Cultures  between healthy subjects  incom- 
patible for one  allele still demonstrated  the widespread  range  in the degree of 
stimulation.  In the latter group,  sample size remained  relatively large. 
63  pairs  of  reactions  were  studied  for which  stimulation  by  a  single  incom- 
patible  allele was  compared  with stimulation  by  the  same  incompatible  allele 
plus  another.  Response  to  the  single  incompatible  allele  in  48  pairs  was  less 
than  or  equal  to  the  response  when  an  additional  allele  was  incompatible. 
However,  in  15  cases  (24%)  in  6  different families,  a  single  allele stimulated 
more than  when it was paired with an additional incompatible  allele. Although 
polymorphism for non-HL-A  antigens  might  account for this  increased stimu- 
lation, very little evidence of stimulation  by non-HL-A  antigens was observed 
in  reactions  between  HL-A-identical siblings.  The  results  from  these  15  cases 
thus  are  unexplained. SEIGLER,  WARD,  AMOS,  PIIAUP,  AND  STICKEL  419 
It was possible  to measure  a  response  to the  same HL-A-incompatibilities 
with  different family pairs  in  14 families  (Table  V).  It is  readily observable 
that the degree of stimulation may be a function of both the stimulating  and 
responding cell.  Response  to  different,  but  HL-A-identical,  siblings  may be 
similar as shown in family 0159 or quite different, as in family 0106. 
With this variability in response by an individual  to the same HL-A allele, 
it  is  not surprising  that  the  same  incompatible  allele  stimulates  different  in- 
dividuals to a different degree. Antigens in both segregant series were defined in 
TABLE VI 
Stimulation Indices for Incompatible HL-A 3, 7 and ItL-A 2, 12 Combinations 
HL-A 3, HL-A 7 
Family 
Stimulating  Responding  Genotypes of SR  SGST  Stimulation 
cells (S)  cells (R)  index 
0082  03  01  BC : AB  ND  2.8 
05  01  BC:AB  ND  4.2 
0206  04  02  AD: CD  15  13,0 
21  02  AD:CD  15  8.0 
0207  06  03  AD :AC  ND  6.5 
06  05  AD :AC  15  5.0 
02  03  CD:AC  ND  6.0 
02  05  CD: AC  13  5.5 
0208  04  01  AC:  AB  15  11.5 
03  01  AC: AB  ND  4.5 
HL-A 2, HL-A  12 
0169 
0139 
06  01  AD :AB  ND  4.0 
07  04  AD:  BD  ND  4.5 
several  families,  but  the  degree  of  stimulation  by  the  same  combination  of 
antigens  was  measured  in  different families  only for  HL-A  3  and  7  and  for 
HL-A 2  and  12  (Table VI). The HL-A 3,  7 combination was associated with 
stimulation  indices  ranging from 2.8  to  13.0,  while  response  to the  HL-A 2, 
12  incompatibility  was  essentially  the  same in both families  in which  it  was 
measured (indices of 4.0 and 4.5).  Comparisons of the mean skin graft survival 
times  (SGST)  and  mean  stimulation  indices  for  the  individual  HL-A speci- 
ficities seem to indicate no significant differences in  the  antigenicity  or  immu- 
nogenicity for the  groups studied  (Table vii). 
Comparison  of  Skin  Graft  Survival  Time  and  HL-A  Alleles.--Previous 
publications  from this  group have reported  the  effects  of HL-A relationships 
on SGST (16). Briefly, skin grafts exchanged between HL-A-identical siblings 420  IMMUNOGENICITY  OF  HUMAN  HL-A  I-IAPLOTYPES 
were found to be distributed about a  mean of 22.4 days with a  range of 15-42 
days,  while  those  exchanged  between  siblings  sharing  neither  HL-A  allele 
were rejected in 6-15 days, mean 11.4. When one HL-A allele was incompatible, 
a  wide  range  of  survival  times  was  observed,  8-28  days,  mean  14.2  days. 
Although rapid rejection could not be associated with any of the individually 
defined ItL-A antigens,  a  statistical association was  observed between  SGST 
and  the  number  of  incompatible  HL-A  specificities.  Skin  graft  survival  in 
these families in  which  MLR  data  is  available is  consistent with  our  earlier 
TABLE VII 
Comparison of Skin Graft Survival Time (Days) and Stimulation Indices/or Various 
Incompatible HL-A Groups: Means and Standard Errors 
Incompatlble  HL-A group 
SGST  MLR stimulating index 
SE  N  ~  SE  N 
First segregant series 
Second segregant series 
HL-A 1  12.5  0.87  4  3.21  0.81  7 
HL-A 2  13.2  0.91  9  7.68  1.65  30 
HL-A 3  15.6  1.24  9  7.78  0.90  25 
HL-A 9  18.0  1  10.62  2.98  8 
HL-A 11  15.5  1.50  2  8.00  2.15  9 
Blank  16.9  0.97  22  5.03  0.44  53 
HL-A 5  12.8  0.51  10  6.25  1.35  8 
HL-A 8  17.4  1.45  11  6.84  0.77  30 
LND  19.7  3.38  3  13.80  6.81  5 
4c  10.0  0.00  2  17.50  6.83  6 
4c*  14.0  1  8.60  2.23  5 
Te 10  2.75  0.75  2 
Blank  15.3  0.72  26  5.96  0.68  87 
findings with the single exception of a graft measuring two allelic incompatibili- 
ties which survived 16 days. 
Comparison of Mixed Leukocyte Reaction  and Skin  Graft  Survival.--Certain 
parallels may be drawn between the MLR  and skin graft survival. A  range of 
values far exceeding that of duplicate tests was observed when either the MLR 
or skin graft survival was measured within any of the classes defined in terms 
of  the  number  of HL-A-incompatible alleles. Stimulation  and  SGST for  the 
groups measuring one incompatible allele covered a wide range, but the average 
values fell between those for HL-A-identical and for two incompatible H_L-A 
alleles.  These  observations  indicate  that  HL-A  affects  both  the  MLR  and 
SGST  but  that  other  factors  probably  influence  them  as  well.  These  other 
factors may not be the same for MLR  and for skin grafts as indicated by the 
low correlation between them (r =  0.25). As Fig. 2  and Table VIII depict, an 
incompatible  allele for  which  the  MLR  stimulation  index  is  high  may  be SEIGLER~  WARD~  AMOS~  PIIAUP~  AND  STICKEL  421 
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FIG. 2.  Scattergram of SGST compared with stimulation indices for the three HL-A classes. 
TABLE VIII 
Comparison of Skin Graft Survival Times and Stimulation Indices 
SGST 
Stimulation index 
<1.5  1.5-2.5  >2.5-5  >5 
_< 15 Days  4  6  11  16 
> 15 Days  15  7  13  10 
2  x3  =  7.27,0.1 P  >  0.05 
associated with a skin graft which survives as few as 8 days or as many as 28 
days. Clearly, one cannot accurately predict SGST on the basis of the degree 
of  stimulation in MLR. 
DISCUSSION 
These data indicate that one cannot directly equate degrees of stimulation 
in the  MLR with the degree  of incompatibility  for  HL-A. One  might argue 422  IMMUNOGENICITY OF  HUMAN  HL-A  ItAPLOTYPES 
that certain HL-A alleles,  when incompatible, do not provoke a response, thus 
accounting for the one-incompatible  allele reactions with no stimulation. The 
probability that both incompatible alleles in the  two-allele difference reactions 
are  nonstimulating  might be  small  enough  to be undetected  in  this  sample. 
One would, however, expect that a reaction measuring  one incompatible allele 
would show less stimulation  than  one measuring the same allele plus another. 
The immunogenicity of HL-A haptotypes has been correlated with test SGST 
(16). Skin graft survival time has been correlated with renal  allograft survival 
as well as with the level of immediate and  long-term renal function  (17). The 
absence of correlation between  the  MLR  and  corresponding SGST indicates 
the failure of the MLR  test to accurately predict the degree of compatibility 
between family pairs. The range of MLR  stimulation index is wide and does 
not  always reflect the  degree of immunogenicity  as  demonstrated by SGST. 
The over-all association of a  higher mean stimulation index with the greater 
number of HL-A alleles which  are incompatible must be carefully examined 
for the numerous exceptions. Absence of different degrees of stimulation when 
different HL-A specificities are  incompatible may reflect biochemical homo- 
geneity underlying the separate antigenic groups. 
These observations might have been predicted since the ultimate response 
to a foreign antigen, particularly in the intact animal, surely depends upon a 
number of factors, all of which are not recognizable in MLR. Ability to recognize 
a particular antigenic configuration may depend upon the mode of presentation 
and perhaps the immunological experience of the individual, particularly with 
respect to cross-reacting antigens.  The over-all correlation of the MLR with 
HL-A genotyping and SGST makes it a valuable asset in donor selection, but 
at this point the major value of MLR is in confirming HL-A identity. 
SUMMARY 
The  immunogenicity  of  the  haplotypes  in  so  families  was  measured  by 
survival of skin grafts between selected paired family members. These families 
were  genotyped  for  HL-A  using  57  selected  cytotoxic alloantisera  defining 
HL-A 1-12 as well as other nondefined specificities. Mixed leukocyte reactions 
were also studied in this series and the correlations between the mixed leukocyte 
reactions with skin graft survival times, individual HL-A specificities, and the 
number of incompatible HL-A alleles are reported. Comments concerning the 
interpretation and quantitation of the mixed leukocyte reactions are discussed. 
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